Methadone Alkaloid (Methadone Hydrochloride)

Methadone works by fully activating the μ‑opioid receptors in the central nervous system, which blocks pain signals and reduces the perception of pain. It also antagonizes NMDA receptors and inhibits the reuptake of serotonin and norepinephrine, actions that contribute to its ability to lessen opioid cravings and withdrawal.

The appropriate dose of Methadone Alkaloid is individualized and set by a qualified prescriber based on the patient’s clinical condition, prior opioid exposure, metabolic status, and response to therapy. Dosing is typically initiated at a low level and titrated cautiously to achieve therapeutic effect while minimizing adverse reactions.

Methadone is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out and the drug should be used only if the potential benefit justifies the potential risk. Limited data suggest that methadone can be excreted in breast milk; therefore, breastfeeding decisions should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Methadone Alkaloid. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Methadone and buprenorphine are the two most common agents for opioid dependence treatment. Methadone is a full μ‑opioid receptor agonist offering stronger analgesia but requires more careful dosing and monitoring for respiratory depression and cardiac effects. Buprenorphine is a partial agonist with a ceiling effect on respiratory depression, making it safer in some settings, though it may provide less analgesic potency.

Methadone Alkaloid should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct light. Ensure the container is tightly closed and keep the product out of reach of children. No refrigeration is required for this oral formulation.

Methadone Alkaloid is administered orally, typically as a tablet or liquid preparation, according to the prescriber’s instructions. The medication is taken with or without food, but consistent administration conditions help maintain stable plasma levels. Patients should follow the dosing schedule precisely and avoid abrupt discontinuation without medical guidance.

The most serious risks include respiratory depression, which can be life‑threatening, especially when combined with other CNS depressants; QT interval prolongation leading to cardiac arrhythmias; severe hypotension; and rare allergic reactions such as anaphylaxis. Patients should be educated to seek immediate medical attention if they experience difficulty breathing, fainting, palpitations, or signs of an allergic reaction.

Methadone Alkaloid should be avoided in individuals with known hypersensitivity to methadone or any component of the formulation, those with uncontrolled severe respiratory disease, significant cardiac conduction abnormalities (e.g., prolonged QT interval), or in patients taking multiple strong CYP3A4 inhibitors without close monitoring. Pregnant women should only use it when the therapeutic benefit outweighs potential fetal risk.